O	0	10	Inhibition	Inhibition	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	18	Dll4	Dll4	NN	B-NP
O	18	19	-	-	HYPH	B-NP
O	19	27	mediated	mediate	VBN	I-NP
O	28	37	signaling	signaling	NN	I-NP
O	38	45	induces	induce	VBZ	B-VP
O	46	59	proliferation	proliferation	NN	B-NP
O	60	62	of	of	IN	B-PP
O	63	71	immature	immature	JJ	B-NP
B-Multi-tissue_structure	72	79	vessels	vessel	NNS	I-NP
O	80	83	and	and	CC	O
O	84	91	results	result	VBZ	B-VP
O	92	94	in	in	IN	B-PP
O	95	99	poor	poor	JJ	B-NP
B-Tissue	100	106	tissue	tissue	NN	I-NP
O	107	116	perfusion	perfusion	NN	I-NP
O	116	117	.	.	.	O

B-Multi-tissue_structure	118	126	Vascular	Vascular	JJ	B-NP
O	127	138	development	development	NN	I-NP
O	139	141	is	be	VBZ	B-VP
O	142	151	dependent	dependent	JJ	B-ADJP
O	152	154	on	on	IN	B-PP
O	155	162	various	various	JJ	B-NP
O	163	169	growth	growth	NN	I-NP
O	170	177	factors	factor	NNS	I-NP
O	178	181	and	and	CC	O
O	182	189	certain	certain	JJ	B-NP
O	190	199	modifiers	modifier	NNS	I-NP
O	200	208	critical	critical	JJ	B-ADJP
O	209	212	for	for	IN	B-PP
O	213	222	providing	provide	VBG	B-VP
B-Multi-tissue_structure	223	231	arterial	arterial	JJ	B-NP
O	232	234	or	or	CC	I-NP
B-Multi-tissue_structure	235	241	venous	venous	JJ	I-NP
O	242	250	identity	identity	NN	I-NP
O	250	251	,	,	,	O
O	252	263	interaction	interaction	NN	B-NP
O	264	268	with	with	IN	B-PP
O	269	272	the	the	DT	B-NP
O	273	284	surrounding	surround	VBG	I-NP
B-Tissue	285	291	stroma	stroma	NN	I-NP
O	292	295	and	and	CC	I-NP
B-Tissue	296	303	tissues	tissue	NNS	I-NP
O	303	304	,	,	,	O
B-Tissue	305	315	hierarchic	hierarchic	JJ	B-NP
I-Tissue	316	323	network	network	NN	I-NP
O	324	333	formation	formation	NN	I-NP
O	333	334	,	,	,	O
O	335	338	and	and	CC	O
O	339	350	recruitment	recruitment	NN	B-NP
O	351	353	of	of	IN	B-PP
B-Cell	354	363	pericytes	pericyte	NNS	B-NP
O	363	364	.	.	.	O

O	365	370	Notch	Notch	NN	B-NP
O	371	380	receptors	receptor	NNS	I-NP
O	381	384	and	and	CC	I-NP
O	385	392	ligands	ligand	NNS	I-NP
O	393	394	(	(	(	O
O	394	400	Jagged	Jag	VBN	B-VP
O	401	404	and	and	CC	O
O	405	410	Delta	Delta	NN	B-NP
O	410	411	-	-	HYPH	O
O	411	415	like	like	JJ	O
O	415	416	)	)	)	O
O	417	421	play	play	VBP	B-VP
O	422	423	a	a	DT	B-NP
O	424	432	critical	critical	JJ	I-NP
O	433	437	role	role	NN	I-NP
O	438	440	in	in	IN	B-PP
O	441	445	this	this	DT	B-NP
O	446	453	process	process	NN	I-NP
O	454	456	in	in	IN	B-PP
O	457	465	addition	addition	NN	B-NP
O	466	468	to	to	TO	B-PP
O	469	473	VEGF	VEGF	NN	B-NP
O	473	474	.	.	.	O

O	475	479	Dll4	Dll4	NN	B-NP
O	480	482	is	be	VBZ	B-VP
O	483	486	one	one	CD	B-NP
O	487	489	of	of	IN	B-PP
O	490	493	the	the	DT	B-NP
O	494	499	Notch	Notch	NN	I-NP
O	500	507	ligands	ligand	NNS	I-NP
O	508	512	that	that	WDT	B-NP
O	513	522	regulates	regulate	VBZ	B-VP
B-Multi-tissue_structure	523	531	arterial	arterial	JJ	B-NP
O	532	545	specification	specification	NN	I-NP
O	546	549	and	and	CC	I-NP
O	550	560	maturation	maturation	NN	I-NP
O	561	567	events	event	NNS	I-NP
O	567	568	.	.	.	O

O	569	571	In	In	IN	B-PP
O	572	575	the	the	DT	B-NP
O	576	583	current	current	JJ	I-NP
O	584	589	study	study	NN	I-NP
O	589	590	,	,	,	O
O	591	593	we	we	PRP	B-NP
O	594	598	have	have	VBP	B-VP
O	599	604	shown	show	VBN	I-VP
O	605	609	that	that	IN	B-SBAR
O	610	614	loss	loss	NN	B-NP
O	615	617	of	of	IN	B-PP
O	618	626	function	function	NN	B-NP
O	627	629	by	by	IN	B-PP
O	630	636	either	either	CC	B-NP
O	637	645	targeted	target	VBN	I-NP
O	646	652	allele	allele	NN	I-NP
O	653	661	deletion	deletion	NN	I-NP
O	662	664	or	or	CC	I-NP
O	665	668	use	use	NN	I-NP
O	669	671	of	of	IN	B-PP
O	672	673	a	a	DT	B-NP
O	674	681	soluble	soluble	JJ	I-NP
O	682	686	form	form	NN	I-NP
O	687	689	of	of	IN	B-PP
O	690	694	Dll4	Dll4	NN	B-NP
B-Immaterial_anatomical_entity	695	708	extracellular	extracellular	JJ	I-NP
O	709	715	domain	domain	NN	I-NP
O	716	721	leads	lead	VBZ	B-VP
O	722	724	to	to	TO	B-PP
O	725	735	inhibition	inhibition	NN	B-NP
O	736	738	of	of	IN	B-PP
O	739	744	Notch	Notch	NN	B-NP
O	745	754	signaling	signaling	NN	I-NP
O	754	755	,	,	,	O
O	756	765	resulting	result	VBG	B-VP
O	766	768	in	in	IN	B-PP
O	769	778	increased	increase	VBN	B-NP
B-Multi-tissue_structure	779	787	vascular	vascular	JJ	I-NP
O	788	801	proliferation	proliferation	NN	I-NP
O	802	805	but	but	CC	O
O	806	815	defective	defective	JJ	B-NP
O	816	826	maturation	maturation	NN	I-NP
O	826	827	.	.	.	O

O	828	833	Newly	Newly	RB	B-ADVP
O	834	841	forming	form	VBG	B-VP
B-Multi-tissue_structure	842	849	vessels	vessel	NNS	B-NP
O	850	854	have	have	VBP	B-VP
O	855	859	thin	thin	JJ	B-NP
B-Immaterial_anatomical_entity	860	867	caliber	caliber	NN	I-NP
O	867	868	,	,	,	O
O	869	870	a	a	DT	B-NP
O	871	879	markedly	markedly	RB	I-NP
O	880	887	reduced	reduce	VBN	I-NP
B-Immaterial_anatomical_entity	888	894	vessel	vessel	NN	I-NP
I-Immaterial_anatomical_entity	895	900	lumen	lumen	NN	I-NP
O	900	901	,	,	,	O
O	902	910	markedly	markedly	RB	B-ADVP
O	911	918	reduced	reduce	VBD	B-VP
B-Cell	919	927	pericyte	pericyte	NN	B-NP
O	928	939	recruitment	recruitment	NN	I-NP
O	939	940	,	,	,	O
O	941	944	and	and	CC	O
O	945	954	deficient	deficient	JJ	B-NP
B-Multi-tissue_structure	955	963	vascular	vascular	JJ	I-NP
O	964	973	perfusion	perfusion	NN	I-NP
O	973	974	.	.	.	O

O	975	980	sDll4	sDll4	NN	B-NP
O	981	990	similarly	similarly	RB	B-ADVP
O	991	998	induced	induce	VBD	B-VP
O	999	1008	defective	defective	JJ	B-NP
B-Multi-tissue_structure	1009	1017	vascular	vascular	JJ	I-NP
O	1018	1026	response	response	NN	I-NP
O	1027	1029	in	in	IN	B-PP
B-Cancer	1030	1035	tumor	tumor	NN	B-NP
O	1036	1044	implants	implant	NNS	I-NP
O	1045	1052	leading	lead	VBG	B-VP
O	1053	1055	to	to	TO	B-PP
O	1056	1063	reduced	reduce	VBN	B-NP
B-Cancer	1064	1069	tumor	tumor	NN	I-NP
O	1070	1076	growth	growth	NN	I-NP
O	1076	1077	.	.	.	O

O	1078	1090	Interference	Interference	NN	B-NP
O	1091	1095	with	with	IN	B-PP
O	1096	1100	Dll4	Dll4	NN	B-NP
O	1100	1101	-	-	HYPH	I-NP
O	1101	1106	Notch	Notch	NN	I-NP
O	1107	1116	signaling	signaling	NN	I-NP
O	1117	1120	may	may	MD	B-VP
O	1121	1123	be	be	VB	I-VP
O	1124	1136	particularly	particularly	RB	B-ADJP
O	1137	1146	desirable	desirable	JJ	I-ADJP
O	1147	1149	in	in	IN	B-PP
B-Cancer	1150	1156	tumors	tumor	NNS	B-NP
O	1157	1161	that	that	WDT	B-NP
O	1162	1166	have	have	VBP	B-VP
O	1167	1173	highly	highly	RB	I-VP
O	1174	1181	induced	induce	VBN	I-VP
O	1182	1186	Dll4	Dll4	NN	B-NP
O	1186	1187	-	-	HYPH	B-NP
O	1187	1192	Notch	Notch	NN	I-NP
O	1193	1200	pathway	pathway	NN	I-NP
O	1200	1201	.	.	.	O

